Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Milestone Scientific (MLSS) Equity Ratio (2016 - 2025)

Milestone Scientific's Equity Ratio history spans 16 years, with the latest figure at 0.3 for Q3 2025.

  • For Q3 2025, Equity Ratio fell 53.51% year-over-year to 0.3; the TTM value through Sep 2025 reached 0.3, down 53.51%, while the annual FY2024 figure was 0.6, 15.51% down from the prior year.
  • Equity Ratio for Q3 2025 was 0.3 at Milestone Scientific, down from 0.41 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.93 in Q2 2022 and bottomed at 0.3 in Q3 2025.
  • The 5-year median for Equity Ratio is 0.7 (2023), against an average of 0.68.
  • The largest annual shift saw Equity Ratio surged 998.73% in 2021 before it plummeted 53.51% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.82 in 2021, then fell by 10.78% to 0.73 in 2022, then dropped by 3.52% to 0.7 in 2023, then dropped by 15.51% to 0.6 in 2024, then plummeted by 49.54% to 0.3 in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Equity Ratio are 0.3 (Q3 2025), 0.41 (Q2 2025), and 0.49 (Q1 2025).